Verona Pharma
VRNA
$13.00
Share price
-2.69%
Change (1 day)
-33.09%
Change (1 year)
Categories
EPS for Verona Pharma (VRNA)
EPS in 2023 (TTM): -$0.64
According to Verona Pharma's latest financial reports the company's current EPS (TTM) is -$0.64. In 2022 the company made an earnings per share (EPS) of -$1.04 a decrease over its 2021 EPS that were of -$1.04.
EPS history for Verona Pharma from 2021 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.64 | -38.46% |
| 2022 | -$1.04 | -0% |
| 2021 | -$1.04 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$0.06000 | -90.63% | Bahamas |
 NRC Health
NRC | $1.19 | -285.94% | 🇺🇸 USA |